Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1Andrew Fesler(Stony Brook University), Jingfang Ju(Stony Brook University)OncotargetDecember 19, 201710.18632/oncotarget.23414Cited by 59SaveCiteExport RISWatch citationsRelated PapersmiR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer|Cell Death and Disease|2013|191Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells|Oncotarget|2017|33